Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P020016/S010

Total Temporomandibular Joint Replacement System

BIOMET MICROFIXATION, INC · Decision date Jul 27, 2026

FDA DECISIONP020016/S010

What did the FDA approve?

FDA records P020016/S010 as a supplement to PMA P020016, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Jul 27, 2026.

FDA approval order statement

APPROVAL FOR PROPOSED LABELING CHANGES FOLLOWING THE CONCLUSION OF THE POSTMARKET SURVEILLANCE STUDY FOR THE TOTAL TEMPOROMANDIBULAR JOINT REPLACEMENT SYSTEM.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Dental
Decision date
Jul 27, 2026
FDA change category
Labeling Change - PAS

FDA source record

Regulatory record facts

Identifier
P020016/S010
Regulatory pathway
PMA supplement
Product code
Not reported
Decision code
APPR
Decision date
Jul 27, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

Product code
Not reported

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P020016/S010 received

    Application receipt date recorded by FDA.

  2. P020016/S013 · Related supplement

    Total Temporomandibular Joint Replacement System

  3. P020016/S010 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P020016. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P020016

Product / regulatory recordCompanyPathwayDecision dateSource
BIOMET MICROFIXATION, INCPMA supplementFeb 19, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

BIOMET MICROFIXATION, INC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1520 Tradeport Dr., Jacksonville, FL, 32218

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records